LifeStance Health Gr Q1 2024 GAAP EPS $(0.06) Beats $(0.08) Estimate, Sales $300.437M Beat $298.991M Estimate
LifeStance Health Gr Q1 2024 GAAP EPS $(0.06) Beats $(0.08) Estimate, Sales $300.437M Beat $298.991M Estimate
LifeStance Health Gr 2024年第一季度GAAP每股收益美元（0.06）超過預期（0.08），銷售額3.00437億美元超過預期的2.989.91億美元
LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $300.437 million which beat the analyst consensus estimate of $298.991 million by 0.48 percent. This is a 18.94 percent increase over sales of $252.589 million the same period last year.
LifeStance Health Gr（納斯達克股票代碼：LFST）公佈的季度虧損爲每股0.06美元，比分析師普遍預期的0.08美元（0.08美元）高出25％。與去年同期每股虧損0.09美元（0.09）相比，增長了33.33％。該公司公佈的季度銷售額爲3.004.37億美元，比分析師普遍預期的2.989.91億美元高出0.48％。這比去年同期的2.52589億美元的銷售額增長了18.94％。